Home › Companies › PACIFIC BIOSCIENCES OF CALIFORNIA INC. › 2024-2025
Compiled from SEC Form N-PX filings and PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s Form 8-K, filed 2025-06-06 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore PACIFIC BIOSCIENCES OF CALIFORNIA INC. in the interactive database Compare manager voting policies
These tallies are PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: William Ericson | 104,132,466 | 24,793,642 | 809,854 | -- | 56,387,161 | Majority: yes |
| Elect Director: Kathy Ordoñez | 126,729,273 | 2,137,971 | 868,718 | -- | 56,387,161 | Majority: yes |
| Elect Director: Christopher M. Smith | 126,830,161 | 2,076,866 | 828,935 | -- | 56,387,161 | Majority: yes |
| Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm | 162,154,849 | 22,599,739 | 1,368,535 | -- | -- | Passed |
| Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation | 78,367,531 | 50,498,020 | 870,411 | -- | 56,387,161 | Passed |
| Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan | 85,355,382 | 43,563,859 | 816,721 | -- | 56,387,161 | Passed |
Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC., Form 8-K, filed with the SEC on 2025-06-06 — read the filing on EDGAR.
Each item below shows how the 212 asset managers that disclosed a PACIFIC BIOSCIENCES OF CALIFORNIA INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
61% Passed · of votes cast
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation”): 78,367,531 for, 50,498,020 against — passed, per its Form 8-K filed 2025-06-06 (Item 5.07). Of all 300,041,000 outstanding shares: 26% for, 17% against (43% of the company cast a for/against vote).
The 211 asset managers below cast 41% of the shares they voted on this item FOR (31,724,105 for, 46,602,755 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Madrone Advisors, LLC | 20,941,915 | 0 | 0 | 0 | For |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 0 | 20,208,780 | 0 | 0 | Against |
| Nikko Asset Management Co., Ltd. | 0 | 9,565,331 | 0 | 0 | Against |
| State Street | 3,866,738 | 52,091 | 0 | 0 | For |
| BlackRock | 405,548 | 1,749,440 | 0 | 0 | Against |
| T. Rowe Price | 0 | 2,088,088 | 0 | 0 | Against |
| Vanguard | 1,622,696 | 34,538 | 0 | 0 | For |
| Jackson Square Partners, LLC | 0 | 1,518,068 | 0 | 0 | Against |
| Northern Trust | 0 | 1,432,912 | 0 | 0 | Against |
| ARK Investment Management LLC | 989,766 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 955,349 | 0 | 0 | Against |
| HHLR ADVISORS, LTD. | 918,892 | 0 | 0 | 0 | For |
| BOURNE LENT ASSET MANAGEMENT INC | 857,855 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 0 | 758,277 | 0 | 0 | Against |
| Casdin Capital, LLC | 0 | 723,767 | 0 | 0 | Against |
| Vestmark Advisory Solutions, Inc. | 0 | 659,750 | 0 | 0 | Against |
| Mirador Capital Partners LP | 0 | 0 | 508,795 | 0 | Abstain |
| MELLON INVESTMENTS Corp | 0 | 496,672 | 0 | 0 | Against |
| ArrowMark Colorado Holdings LLC | 0 | 468,382 | 0 | 0 | Against |
| Charles Schwab | 0 | 454,287 | 0 | 0 | Against |
| Universal-Investment-Gesellschaft mbH | 0 | 408,700 | 0 | 0 | Against |
| Fidelity | 297,774 | 105,422 | 0 | 0 | For |
| Lincoln Financial | 199,698 | 191,106 | 0 | 0 | For |
| Two Sigma | 0 | 304,430 | 0 | 0 | Against |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 0 | 300,406 | 0 | 0 | Against |
Showing the 25 largest of 211 asset managers. See all 211 in the interactive database.
66% Passed · of votes cast
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan”): 85,355,382 for, 43,563,859 against — passed, per its Form 8-K filed 2025-06-06 (Item 5.07). Of all 300,041,000 outstanding shares: 28% for, 15% against (43% of the company cast a for/against vote).
The 44 asset managers below cast 65% of the shares they voted on this item FOR (4,179,563 for, 2,229,148 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 879,921 | 0 | 0 | Against |
| Managed Portfolio Series | 0 | 758,277 | 0 | 0 | Against |
| Lincoln Financial | 199,398 | 191,106 | 0 | 0 | For |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 134,010 | 0 | 0 | Against |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 119,722 | 0 | 0 | 0 | For |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 0 | 100,000 | 0 | 0 | Against |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 0 | 42,401 | 0 | 0 | Against |
| ProShares | 0 | 40,477 | 0 | 0 | Against |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 0 | 26,094 | 0 | 0 | Against |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Christopher M. Smith”): 126,830,161 for, 2,076,866 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 300,041,000 outstanding shares: 42% for, 0.7% against (43% of the company cast a for/against vote).
The 43 asset managers below cast 98% of the shares they voted on this item FOR (6,286,883 for, 119,722 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 390,504 | 0 | 0 | 0 | For |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 0 | 119,722 | 0 | 0 | Against |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 26,094 | 0 | 0 | 0 | For |
Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Kathy Ordoñez”): 126,729,273 for, 2,137,971 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 300,041,000 outstanding shares: 42% for, 0.8% against (43% of the company cast a for/against vote).
The 43 asset managers below cast 97% of the shares they voted on this item FOR (6,239,047 for, 167,558 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 375,237 | 15,267 | 0 | 0 | For |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 0 | 119,722 | 0 | 0 | Against |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 26,094 | 0 | 0 | 0 | For |
Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.
Combines 2 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: William Ericson”): 104,132,466 for, 24,793,642 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 300,041,000 outstanding shares: 35% for, 8% against (43% of the company cast a for/against vote).
The 43 asset managers below cast 86% of the shares they voted on this item FOR (5,486,995 for, 919,610 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 375,237 | 15,267 | 0 | 0 | For |
| Fidelity | 239,027 | 105,422 | 0 | 0 | For |
| BlackRock | 0 | 284,215 | 0 | 0 | Against |
| Equitable | 217,760 | 47,451 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 138,093 | 0 | 0 | Against |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 123,029 | 0 | 0 | Against |
| Investment Managers Series Trust II | 0 | 119,722 | 0 | 0 | Against |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 0 | 27,748 | 0 | 0 | Against |
| Calvert | 0 | 26,094 | 0 | 0 | Against |
Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.
88% Passed · of votes cast
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm”): 162,154,849 for, 22,599,739 against — passed, per its Form 8-K filed 2025-06-06 (Item 5.07). Of all 300,041,000 outstanding shares: 54.0% for, 8% against (62% of the company cast a for/against vote).
The 43 asset managers below cast 100% of the shares they voted on this item FOR (6,406,605 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 390,504 | 0 | 0 | 0 | For |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 119,722 | 0 | 0 | 0 | For |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 26,094 | 0 | 0 | 0 | For |
Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.
Ranked by the number of PACIFIC BIOSCIENCES OF CALIFORNIA INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 300,041,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Madrone Advisors, LLC | 6.98% |
| 2 | EDMOND DE ROTHSCHILD HOLDING S.A. | 6.74% |
| 3 | Nikko Asset Management Co., Ltd. | 3.19% |
| 4 | State Street | 1.31% |
| 5 | BlackRock | 0.72% |
| 6 | T. Rowe Price | 0.70% |
| 7 | Vanguard | 0.55% |
| 8 | Jackson Square Partners, LLC | 0.51% |
| 9 | Northern Trust | 0.48% |
| 10 | ARK Investment Management LLC | 0.33% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| ARK Investment Management LLC | 12.42% | 13G |
| Madrone Opportunity Fund, L.P. | 8.96% | DEF14A |
| BlackRock | 7.82% | 13F |
| SB Northstar LP | 6.82% | DEF14A |
| Vanguard Group | 5.42% | 13F |
| EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 4.45% | 13G |
| Gregory Boyd Penner | 2.82% | 13G |
| State Street | 2.13% | 13F |
| Geode Capital | 2.11% | 13F |
| Morgan Stanley | 1.12% | 13F |
Percentages above are of 300,041,000 shares outstanding, as reported by PACIFIC BIOSCIENCES OF CALIFORNIA INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s shareholder meeting held 2025-06-04, in the 2024-2025 proxy season, 212 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 914 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — the proposal passed with 61% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-06.
PACIFIC BIOSCIENCES OF CALIFORNIA INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.